Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
T-Safe 380A QL intrauterine contraceptive device
21040000265
|
T-Safe 380A QL intrauterine contraceptive device | Contraceptive Devices | Appliances | 6,131 |
|
Nova-T 380 intrauterine contraceptive device
21040000261
|
Nova-T 380 intrauterine contraceptive device | Contraceptive Devices | Appliances | 2,992 |
|
Copper T380 A intrauterine contraceptive device
21040000266
|
Copper T380 A intrauterine contraceptive device | Contraceptive Devices | Appliances | 1,492 |
|
Neo-Safe T380 intrauterine contraceptive device
21040000275
|
Neo-Safe T380 intrauterine contraceptive device | Contraceptive Devices | Appliances | 407 |
|
Eurogine T 380 Cu intrauterine contraceptive device mini/normal
21040000263
|
Eurogine T 380 Cu intrauterine contraceptive device mini/normal | Contraceptive Devices | Appliances | 380 |
|
TT380 Slimline intrauterine contraceptive device
21040000285
|
TT380 Slimline intrauterine contraceptive device | Contraceptive Devices | Appliances | 232 |
|
Optima TCu 380A intrauterine contraceptive device
21040000278
|
Optima TCu 380A intrauterine contraceptive device | Contraceptive Devices | Appliances | 128 |
|
Mini TT380 Slimline intrauterine contraceptive device
21040000286
|
Mini TT380 Slimline intrauterine contraceptive device | Contraceptive Devices | Appliances | 126 |
|
Eurogine T 380 Ag intrauterine contraceptive device mini/normal
21040000262
|
Eurogine T 380 Ag intrauterine contraceptive device mini/normal | Contraceptive Devices | Appliances | 104 |
|
UT380 Standard intrauterine contraceptive device
21040000291
|
UT380 Standard intrauterine contraceptive device | Contraceptive Devices | Appliances | 12 |
|
Flexi-T+ 380 intrauterine contraceptive device
21040000248
|
Flexi-T+ 380 intrauterine contraceptive device | Contraceptive Devices | Appliances | 9 |
|
Multi-Safe 375 intrauterine contraceptive device
21040000270
|
Multi-Safe 375 intrauterine contraceptive device | Contraceptive Devices | Appliances | 8 |
|
Flexi-T 300 intrauterine contraceptive device
21040000247
|
Flexi-T 300 intrauterine contraceptive device | Contraceptive Devices | Appliances | 7 |
|
UT380 Short intrauterine contraceptive device
21040000290
|
UT380 Short intrauterine contraceptive device | Contraceptive Devices | Appliances | 5 |
|
FemCap 26mm
21040000431
|
FemCap 26mm | Contraceptive Devices | Appliances | 3 |
|
Ancora 375 Cu intrauterine contraceptive device
21040000258
|
Ancora 375 Cu intrauterine contraceptive device | Contraceptive Devices | Appliances | 1 |
|
FemCap 30mm
21040000432
|
FemCap 30mm | Contraceptive Devices | Appliances | 1 |
|
GyneFix intrauterine contraceptive device
21040000245
|
GyneFix intrauterine contraceptive device | Contraceptive Devices | Appliances | 1 |
|
Multiload Cu375 intrauterine contraceptive device
21040000256
|
Multiload Cu375 intrauterine contraceptive device | Contraceptive Devices | Appliances | 1 |
|
Ancora 375 Ag intrauterine contraceptive device
21040000257
|
Ancora 375 Ag intrauterine contraceptive device | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.1
21040000311
|
Dumas Vault Cap No.1 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.2
21040000312
|
Dumas Vault Cap No.2 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.3
21040000313
|
Dumas Vault Cap No.3 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.4
21040000314
|
Dumas Vault Cap No.4 | Contraceptive Devices | Appliances | No data available |
|
Dumas Vault Cap No.5
21040000315
|
Dumas Vault Cap No.5 | Contraceptive Devices | Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.